GWA Group Ltd
ASX:GWA
GWA Group Ltd
GWA Group Ltd. engages in the research, design, manufacture, import, and marketing of building fixtures and fittings to households and commercial premises. The firm is focused on the research, design, import and marketing of building fixtures and fittings to residential and commercial premises and the distribution of various products through a range of distribution channels in Australia, New Zealand, United Kingdom and China. Its water solutions segment includes the sale of vitreous China toilet suites, basins, plastic cisterns, taps and showers, baths, kitchen sinks, laundry tubs, domestic water control valves, smart products and bathroom accessories. The firm's brands include Caroma, Methven, Dorf and CLARK. Its Caroma brand include products such as Caroma GermGard and Caroma Smart Command. Caroma GermGard is an antimicrobial formula that kills approximately 99% of bacteria that comes into contact with products.
GWA Group Ltd. engages in the research, design, manufacture, import, and marketing of building fixtures and fittings to households and commercial premises. The firm is focused on the research, design, import and marketing of building fixtures and fittings to residential and commercial premises and the distribution of various products through a range of distribution channels in Australia, New Zealand, United Kingdom and China. Its water solutions segment includes the sale of vitreous China toilet suites, basins, plastic cisterns, taps and showers, baths, kitchen sinks, laundry tubs, domestic water control valves, smart products and bathroom accessories. The firm's brands include Caroma, Methven, Dorf and CLARK. Its Caroma brand include products such as Caroma GermGard and Caroma Smart Command. Caroma GermGard is an antimicrobial formula that kills approximately 99% of bacteria that comes into contact with products.
Revenue Growth: GWA delivered a 2% increase in group revenue for the half, with volume and sales growth across all key markets.
Earnings Up: Normalized EBIT rose by 3%, and statutory net profit after tax increased by 14.9%, reflecting disciplined cost management.
Margins Improved: EBIT margin improved to 18.5%, up 0.2 percentage points from the prior period.
Strong Cash Flow: Operating cash flow was $43.6 million, and the cash conversion ratio remained high at 92%.
Dividend Raised: Interim dividend increased by 6.7% to $0.08 per share, fully franked, and part of a $30 million share buyback underway.
Market Conditions: Management reported resilient performance despite competitive pricing pressure and mixed market environments, especially in Australia and New Zealand.
Strategic Product Launches: Continued investment in new product development, including launch of an AI-enabled leak detection pilot in partnership with Phyn.
